Revolutionizing Healthcare: A New Era in Neurovascular Robotics Unveiled at OCIN 2024

The 2024 Oriental Conference of Interventional Neurovascology (OCIN) showcased significant advancements in neurovascular treatment. Key highlights included the PANVIS series of interventional robotic systems developed by Shenzhen Institute of Advanced Biomedical Robot Co., Ltd. These innovations promise enhanced precision, safety, and accessibility, particularly in remote surgeries, underscoring China’s growing prowess in medical technology.

October witnessed a gathering of great minds at the 2024 Oriental Conference of Interventional Neurovascology (OCIN) in Shanghai, a hub of innovation for neurovascular treatment. The event, organized by the Shanghai Medical Association, highlighted future-defining advances in the field.

The PANVIS series by Shenzhen Institute of Advanced Biomedical Robot Co., Ltd. took center stage, showcasing the potential of interventional robotics to transform surgical precision and safety. With the unveiling of their Class III Medical Device Registration Certificate, these systems epitomize independent innovation in China's high-tech medical sector.

Demonstrations of remote cerebrovascular surgery drew attention to the vast opportunities for addressing healthcare accessibility challenges globally. These technological strides emphasize a commitment to integrating medicine and engineering, setting new benchmarks for excellence in the medical device industry.

(With inputs from agencies.)